Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bhavani G. Murugesan"'
Autor:
Mahmoudreza Moein, Jonathan Capelin, Joseph F. Toth, Dylan Tylor, Zoe M. Weiss, Bhavani G. Murugesan, Reza F. Saidi
Publikováno v:
Surgery in Practice and Science, Vol 9, Iss , Pp 100077- (2022)
Background: Liver transplantation is the only known curative treatment option for end-stage liver diseases and failure; however, there is an imbalance between the number of available liver organs for transplant and the number of patients as recipient
Externí odkaz:
https://doaj.org/article/a009e8fd99884dc69da1bfb2558a7751
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a30024d8a3bf19574a0309118ccd11b0
https://doi.org/10.7759/cureus.37372
https://doi.org/10.7759/cureus.37372
Publikováno v:
American Journal of Gastroenterology. 117:e1421-e1422
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc55774e42534837077807438554783e
https://doi.org/10.14309/01.ajg.0000864972.42722.f6
https://doi.org/10.14309/01.ajg.0000864972.42722.f6
Publikováno v:
Cureus
Landau-Kleffner syndrome (LKS) is a rare childhood neurological condition that causes developmental regression, loss of language skills and abnormal electroencephalogram (EEG) patterns. Its etiology is unknown. This report describes a case of a 13-ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c68f2999e0a7420e2545a80e6acfe0d1
https://doi.org/10.7759/cureus.9385
https://doi.org/10.7759/cureus.9385
Autor:
Hirotsugu Kenmotsu, Mrinal M. Gounder, Gary K. Schwartz, David M. Hyman, Bhavani G. Murugesan, Johanna C. Bendell, Patricia LoRusso, Junichiro Watanabe, Akira Ono, Jonathan Greenberg, Alan Loh Ho, Prasanna Kumar, Yibin Wang, Ved Desai, Ryota Shiga, David R. Spriggs, Joseph Silva, Takahiro Jikoh, Takahiro Tsushima, Tateaki Naito, Tomoya Yokota
Publikováno v:
British Journal of Cancer
Background We examined the impact of race on the maximum tolerated doses (MTD) and final approved doses (FAD) of single-agent molecular-targeted agents (MTA) in North America/Europe (NA/EU) and Asia. Methods We searched PubMed and regulatory database
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dd0ac1396e85d15e033cc4ced3d705c
https://pubmed.ncbi.nlm.nih.gov/29795308
https://pubmed.ncbi.nlm.nih.gov/29795308
Autor:
Ryota Shiga, Bhavani G. Murugesan, Junichiro Watanabe, Patricia LoRusso, Tateaki Naito, Prasanna Kumar, Jonathan Greenberg, Takahiro Tsushima, Hirotsugu Kenmotsu, Tomoya Yokota, Joseph Silva, Takahiro Jikoh, Johanna C. Bendell, Ved Desai, Mrinal M. Gounder, Akira Ono, Yibin Wang, Alan Loh Ho
Publikováno v:
Journal of Clinical Oncology. 35:2536-2536
2536 Background: The aim of this study was to determine the safety, maximum-tolerated dose (MTD), pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of DS-7423, a novel inhibitor of PI3K/mTOR, in US and Japanese population. We further compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22a02d0599369d5651676406692a2bf1
https://doi.org/10.1200/jco.2017.35.15_suppl.2536
https://doi.org/10.1200/jco.2017.35.15_suppl.2536